Open access · CC-BY
via OpenAlex
NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells
Joanna Ratajczak, Magali Joffraud, Samuel A.J. Trammell, Rosa Ras, Núria Canela-Canela, Marie Boutant, Sameer S. Kulkarni, Marcelo Rodrigues Rodrigues, Philip Redpath, Marie E. Migaud, Johan H. Auwerx, Óscar Yanes, Charles Brenner, Carles Cantó
Nature Communications · 2016 · ▲ 378 citations
Abstract
Abstract NAD + is a vital redox cofactor and a substrate required for activity of various enzyme families, including sirtuins and poly(ADP-ribose) polymerases. Supplementation with NAD + precursors, such as nicotinamide mononucleotide (NMN) or nicotinamide riboside (NR), protects against metabolic disease, neurodegenerative disorders and age-related physiological decline in mammals. Here we show that nicotinamide riboside kinase 1 (NRK1) is necessary and rate-limiting for the use of exogenous NR and NMN for NAD + synthesis. Using genetic gain- and loss-of-function models, we further demonstrate that the role of NRK1 in driving NAD + synthesis from other NAD + precursors, such as nicotinamide or nicotinic acid, is dispensable. Using stable isotope-labelled compounds, we confirm NMN is metabolized extracellularly to NR that is then taken up by the cell and converted into NAD + . Our results indicate that mammalian cells require conversion of extracellular NMN to NR for cellular uptake and NAD + synthesis, explaining the overlapping metabolic effects observed with the two compounds.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/ncomms13103
- Canonical
- link ↗
- Fetched
- 2026-10-30 MST
Cite this
APA
Ratajczak, J., Joffraud, M., Trammell, S.A., Ras, R., Canela-Canela, N., Boutant, M., Kulkarni, S.S., Rodrigues, M.R., Redpath, P., Migaud, M.E., Auwerx, J.H., Yanes, �., Brenner, C., & Cantó, C. (2016). NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. <em>Nature Communications</em>. https://doi.org/10.1038/ncomms13103
Vancouver
Ratajczak J, Joffraud M, Trammell SA, Ras R, Canela-Canela N, Boutant M, et al. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. Nature Communications. 2016. doi:10.1038/ncomms13103.
BibTeX
@article{joanna2016NRKcon,
title = {NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells},
author = {Joanna Ratajczak and Magali Joffraud and Samuel A.J. Trammell and Rosa Ras and Núria Canela-Canela and Marie Boutant and Sameer S. Kulkarni and Marcelo Rodrigues Rodrigues and Philip Redpath and Marie E. Migaud and Johan H. Auwerx and Óscar Yanes and Charles Brenner and Carles Cantó},
journal = {Nature Communications},
year = {2016},
doi = {10.1038/ncomms13103},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature 2021
Preprint · OA
Faculty Opinions recommendation of NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells.
npj Metabolic Health and Disease 2025
Open access · CC-BY
The role of NAD+ metabolism and its modulation of mitochondria in aging and disease
Cell Reports 2018
Open access · CC-BY
The NAD+ Precursor Nicotinamide Riboside Rescues Mitochondrial Defects and Neuronal Loss in iPSC and Fly Models of Parkinson’s Disease
Metabolites 2019
Open access · CC-BY
Degradation of Extracellular NAD+ Intermediates in Cultures of Human HEK293 Cells
Mechanisms of Ageing and Development 2021
Open access · CC-BY
Preclinical and clinical evidence of NAD+ precursors in health, disease, and ageing
Current Opinion in Cardiology 2026
Citation only